World Journal of Surgical Oncology (Aug 2023)

Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification

  • Jun-Zhe Zhang,
  • Chuan-Xin Yang,
  • Si Gao,
  • Jun-Feng Bu,
  • Qin-Qin Li,
  • Hao-Lu Wang,
  • Kai-Ni Yang,
  • Shan-Shi Tong,
  • Li-Jun Qian,
  • Jin Zhang,
  • Rong Hua,
  • Yong-Wei Sun,
  • Jia-Yan Yan,
  • Wei Chen

DOI
https://doi.org/10.1186/s12957-023-03126-2
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Background As digital medicine has exerted profound influences upon diagnosis and treatment of hepatobiliary diseases, our study aims to investigate the accuracy of three-dimensional visualization and evaluation (3DVE) system in assessing the resectability of hilar cholangiocarcinoma (hCCA), and explores its potential clinical value. Materials and methods The discovery cohort, containing 111 patients from April 2013 to December 2019, was retrospectively included to determine resectability according to revised criteria for unresectability of hCCA. 3D visualization models were reconstructed to evaluate resectability parameters including biliary infiltration, vascular involvement, hepatic atrophy and metastasis. Evaluation accuracy were compared between contrast-enhanced CT and 3DVE. Logistic analysis was performed to identify independent risk factors of R0 resection. A new comprehensive 3DVE classification of hCCA based on factors influencing resectability was proposed to investigate its role in predicting R0 resection and prognosis. The main outcomes were also analyzed in cohort validation, including 34 patients from January 2020 to August 2022. Results 3DVE showed an accuracy rate of 91% (95%CI 83.6–95.4%) in preoperatively evaluating hCCA resectability, significantly higher than 81% (95%CI 72.8–87.7%) of that of CT (p = 0.03). By multivariable analysis, hepatic artery involvement in 3DVE was identified an independent risk factor for R1 or R2 resection (OR = 3.5, 95%CI 1.4,8.8, P < 0.01). New 3DVE hCCA classification was valuable in predicting patients’ R0 resection rate (p < 0.001) and prognosis (p < 0.0001). The main outcomes were internally validated. Conclusions 3DVE exhibited a better efficacy in evaluating hCCA resectability, compared with contrast-enhanced CT. Preoperative 3DVE demonstrated hepatic artery involvement was an independent risk factor for the absence of R0 margin. 3DVE classification of hCCA was valuable in clinical practice.

Keywords